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Abstract
Background: Bacillus anthracis secretes several virulence factors targeting different host organs and cell
types during inhalational anthrax infection. The bacterial expression of a key virulence factor, lethal toxin
(LeTx) is closely tied to another factor, edema toxin (EdTx). Both are transcribed on the same virulence
plasmid (pXO1) and both have been the subject of much individual study. Their combined effect during
virulent anthrax likely modulates both the global transcriptional and the phenotypic response of
macrophages and phagocytes. In fact, responses brought about by the toxins may be different than each
of their individual effects.
Results: Here we report the transcriptional and apoptotic responses of the macrophage-like phagocytic
cell line THP-1 exposed to B. anthracis Sterne (pXO1+) spores, and B. anthracis Δ Sterne (pXO1-) spores.
These cells are resistant to LeTx-induced cytolysis, a phenotype seen in macrophages from several mouse
strains which are sensitive to toxigenic anthrax infection. Our results indicate that the pXO1-containing
strain induces higher pro-inflammatory transcriptional responses during the first 4 hours of interaction
with bacterium, evident in the upregulation of several genes relevant to Nf-κB, phosphatases,
prostaglandins, and TNF-α, along with decreases in expression levels of genes for mitochondrial
components. Both bacterial strains induce apoptosis, but in the toxigenic strain-challenged cells, apoptosis
is delayed.
Conclusion: This delay in apoptosis occurs despite the much higher level of TNF-α secretion induced by
the toxigenic-strain challenge. Interestingly, CFLAR, an important apoptotic inhibitor which blocks
apoptosis induced by large amounts of extracellular TNF-α, is upregulated significantly during toxigenic-
strain infection, but not at all during non-toxigenic-strain infection, indicating that it may play a role in
blocking or delaying TNF-α-mediated apoptosis. The suppression of apoptosis by the toxigenic anthrax
strain is consistent with the notion that apoptosis itself may represent a protective host cell response.
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Background
Highly pathogenic strains of Bacillus anthracis contain two
plasmids, XO1 and XO2 encoding major virulence factors
of this Gram-positive bacillus. Lethal toxin (LeTx) and
edema toxin (EdTx) genes reside on the pXO1, while the
anti-phagocytic capsule is encoded by pXO2. LeTx is nec-
essary for pathogenicity, as deletion of its gene renders the
microbe avirulent, while EdTx-knockout strains are only
partially attenuated [1]. Capsule substantially contributes
to the virulence of the microbe but unencapsulated
strains, such as Sterne (34F2), are still capable of causing
death in experimental animals [1,2] Therefore, the
pXO1+, pXO2- Sterne strain serves as a convenient experi-
mental toxigenic model of highly virulent strains.
During inhalational exposure to B. anthracis, the spores
may enter alveoli where they become deposited on
mucosal surfaces. Within hours of the initial interactions
with the host, the spores can be engulfed by phagocytes,
such as monocyte-derived macrophages or dendritic cells
[3,4]. Both LeTx and EdTx are expressed upon germina-
tion within the macrophage phagosome [3] and seem to
play important roles in suppressing the bactericidal innate
immune mechanisms of the epithelium and the intra-
phagocytic environment [3,5-9]. In a currently accepted
model of anthrax, some of the phagocytosed spores en
route to the mediastinal lymph nodes survive and multi-
ply within the phagolysosome, kill the cell, and become
released into the lymphatic system [5]. In the following
process of hemorrhagic lymph node destruction, the bac-
teria gain access to the bloodstream and quickly become
systemic by spreading to the spleen and other internal
organs[10,11]. According to this mechanism, lung phago-
cytes such as macrophages and dendritic cells are critically
involved in the initiation of the disease, and their
response to anthrax spores, among other factors, deter-
mines whether the exposure to aerosolized spores results
in the infectious process [12].
Macrophages were the first cell type discovered to die after
exposure to LeTx [13]. LeTx consists of a heptameric pro-
tective antigen (PA) noncovalently associated with lethal
factor (LeF). LeTx is a zinc metalloprotease, which cleaves
and thus inhibits mitogen-activated protein kinase kinase
(MAPKK) family members in vitro and in vivo, resulting in
defective host cell signaling [14-16], with broad implica-
tions for the host innate and adaptive immune responses
[17]. However the death of macrophages after exposure to
LeTx in vitro does not correlate with the cleavage of the
MAPKK substrates by LeTx, and the macrophages sensitive
to LeTx reside in the strains of mice tending to be resistant
to the lethal effect of LeTx [2,18]. This paradoxical effect
did not get a satisfactory mechanistic explanation till it
was discovered that LeTx was able to induce the process of
programmed, apoptotic death in a murine macrophage
cell line RAW 264.7 [19]. It was suggested that for sensi-
tive macrophages, and perhaps other cell types, undergo-
ing apoptosis may serve as an in vivo sensor alerting the
immune system and inducing the protective response
[20]. Similar correlation between macrophage susceptibil-
ity to apoptosis and the outcome of infection in mice
takes place, for example, in the case of M. tuberculosis [21-
23]. Generally, pneumonic macrophages appear to
exhibit a broad apoptotic response during less virulent M.
tuberculosis infection, while infection with more virulent
strains correlates with a near complete loss of the same
apoptotic indicators [23].
Several studies have found that resistance of cells to LeTx
may vary depending on the conditions of growth or stim-
ulation. Human peripheral blood monocytes with the
LeTx-resistant phenotype become sensitive to LeTx upon
growth media deprivation leading to a cellular stress [6].
This finding was further elaborated, when it was shown
that the stress factors in vitro sensitizing murine macro-
phages to apoptosis include a range of the bacterial Toll-
like receptor (TLR) agonists of different nature, including
the pore-forming hemolysins, peptidoglycan or endo-
toxin [24]. Human U-937, HL-60 and THP-1 cell lines of
monocyte origin are resistant to LeTx but become sensi-
tized upon phorbol myristate acetate (PMA)-induced dif-
ferentiation into macrophages in culture [25], although
relevance of this stimulation to the infection process in
vivo is not clear. Additionally, PMA-induction may yield
significant changes in the transcriptome which do not
occur in vivo[26].
In contrast to the LeTx-exposed cells, human peripheral
blood monocytes and monocyte-like undifferentiated
THP-1 cells readily become apoptotic after exposure to B.
anthracis spores [6]. These observations suggest that the
process of infection may involve sensitization of cells to
LeTx through the activity of unknown factors, such as the
bacterial TLR agonists, similar to the effects of these ago-
nists in vitro[24]. Another possibility is the existence of
apoptotic factor(s) independent of LeTx or working in
concert with it. In order to explore these hypotheses we
decided to obtain insight into the transcriptional and
apoptotic responses of THP-1 cells challenged with B.
anthracis spores. To identify host signaling associated with
the pathogenic activity of pXO1-encoded bacterial factors
we compared the effects of the toxigenic (pXO1+, pXO2-)
Sterne strain and the non-toxigenic (pXO1-, pXO2-)  Δ
Sterne strain. In experimental animals the toxigenic strain,
even in the absence of capsule-encoding pXO2, is able to
cause a lethal systemic infection, while a non-toxigenic
strain is non-lethal and causes no clinical symptoms of
disease. We therefore suggested that the use of the
matched pair of isogenic strains would provide a means toBMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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distinguish between the pathogenic and the protective
host responses.
We demonstrate that the presence of toxin plasmid XO1
in the challenge strain results in higher pro-inflammatory
responses. Both B. anthracis strains induce apoptosis,
albeit by different mechanisms. Our data supports a
hypothesis that in the presence of pXO1, apoptosis may
proceed through the mitochondria-dependent pathway,
while in the non-toxigenic infection it seems likely to be
activated mainly through an extrinsic TNF-α receptor-
mediated caspase-8 pathway. The onset of apoptosis
induced by a toxigenic strain is markedly delayed, and key
apoptotic inhibitors are clearly induced, indicating that
the suppression of early apoptosis in phagocytic cells may
be beneficial for the virulent microbe. The fact that pXO1
is not required for the induction of apoptosis suggests that
in addition to LeTx, B. anthracis possesses chromosoma-
lly-encoded pro-apoptotic factor(s).
Results
Growth characteristics indicate increased bacterial 
replication in the presence of THP-1 during early growth
A Bacillus anthracis Δ Sterne strain was selected which was
negative for the toxigenic XO1 plasmid, identical in
genomic variable sequences checked, and which had iden-
tical growth characteristics to its parent Sterne strain
(Additional files 1 and 2). THP-1 cells were challenged
with spores of the Sterne strain and Δ Sterne strains, the
bacterial growth monitored, and THP-1 mRNA was
extracted at early time points to be used for microarray
analysis. Figure 1 shows the bacterial growth represented
by simple absorbance at 2 to 8 h post-coincubation with
THP-1. In the non-toxigenic challenge, there is no statisti-
cally significant difference between challenge with or
without THP-1 other than the MOI-dependent difference.
This is in contrast to the Sterne-challenge, which indicates
more bacterial replication in the presence of THP-1 at
both MOIs.
Principal component analysis indicates a suppressed 
response to toxigenic strains during early (2 h) infection
THP-1 mRNA was collected at 0, 2, and 4 h time points,
and the transcriptional response determined by microar-
rays. Principal component analysis of the microarray
results shows time- and dose-dependent responses by
THP-1 cells during challenge by both strains of B. anthracis
(Fig. 2A). Variation attributed to each component is also
shown (Fig 2B). Data points clustered in the PCA and con-
firmed that the principal components of the data set are
the experimental variables such as MOI, post exposure
time and the nature of the challenge strain. Therefore the
mRNA expression levels reflect changes depending on the
differences in treatment conditions rather than experi-
mental artifacts. As expected, PCA also closely grouped
the results with respect to chip replicates indicating their
consistency, and allowed us to evaluate the overall
dynamics of cell responses (Fig. 2). The results of the 2-
hour challenges by toxigenic Sterne strain spores at both
MOIs cluster in the 3-dimensional parameter space close
Incubation of A) B. anthracis Sterne, or B) B. anthracis Δ Sterne, in serum-free media with or without 1 × 106 THP-1 cells, and at  multiplicities of infection (MOI) of either 1:1 or 1:10 of THP-1 to bacterium Figure 1
Incubation of A) B. anthracis Sterne, or B) B. anthracis Δ Sterne, in serum-free media with or without 1 × 106 
THP-1 cells, and at multiplicities of infection (MOI) of either 1:1 or 1:10 of THP-1 to bacterium.
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A) Principle component analysis of microarrays run in this study confirms groupings of similar treatments, time points, and  experimental replicates Figure 2
A) Principle component analysis of microarrays run in this study confirms groupings of similar treatments, 
time points, and experimental replicates. Each color corresponds to the same experimental treatment, while each point 
represents a separate chip. Axes labeled PC1, PC2, and PC3 and represent Principle Component 1, Principle Component 2, 
and Principle Component 3, respectively. B) Variance of principle components evaluated.
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to the control samples within the same quadrant of our
PCA, in contrast to the cell responses to 2-hour challenges
by Δ Sterne spores. This demonstrates that THP-1 cells
respond to the non-toxigenic infection faster, compared
to the toxigenic one, in agreement with the hypothesis
that the initial general response of macrophages to the vir-
ulent spores is suppressed due to the presence of the LeTx-
expressing plasmid [17]. At the 4-hour time point, there
are notable and discernable differences between Sterne
and Δ Sterne strain-challenged cells indicating a clear dis-
tinction in cellular responses between the strains with
regard to the presence of the toxigenic plasmid. The strain-
specific separation at higher MOIs and time points is so
distinct that it may be useful in delineating toxigenic vs.
non-toxigenic strains. Further confidence in our gene chip
data was obtained using Real-Time PCR (Fig. 3), which
demonstrates the results overall correlating to the micro-
array data within the experimental variations of both data
sets.
Gene ontology comparisons yield known and unknown 
differences
Fig. 4 shows clustered heatmaps of important biological
processes, molecular functions, and cellular component
modules. In general, our results for both strains appear
consistent with the macrophage and innate immune acti-
vation programs described in response to other bacterial
pathogens [27,28]. Activation of innate and other
immune defenses and inflammatory responses are typi-
cally observed for both spore strains, but in general the
activation is greater in the case of the more virulent Sterne
strain spore-challenge model (Fig. 4a) in spite of the over-
all initial delay noticed in the 2-hour challenges. Several
of the NF-κB-controlled programs are upregulated simi-
larly between both strains, indicating that they are pXO1-
independent, while the others could be considered as
characteristics of virulence. The most striking differences
seen between strain challenges in our clustering analyses
consist of a series of modules that are activated at the 4-
hour time points in the Sterne spore treatments, while no
activation is seen in any of the Δ Sterne spore treatments.
Among these modules, there are important signaling
pathway processes, including at least 10 phosphatase
modules, DNA modification modules, and transcrip-
tional regulation modules. In addition, the pathways
involved in eicosanoid and prostaglandin-type metabo-
lism are similarly affected, which agrees with reports on
drastic changes in prostaglandin levels during toxigenic-
anthrax pathogenesis in mice [29]. Other cellular compo-
nent functions encompassing catabolic and metabolic
components do not show much variation between strains,
similar to nucleotide/nucleic acid and ATP metabolism
and catabolic processes (Fig 4b, c). Interestingly though,
the cytochrome oxidase and oxidoreductase modules
appear highly activated early in the avirulent Δ Sterne
strain challenge, in comparison to the Sterne strain, mark-
ing the suppression of the transcriptional-level mitochon-
drial activation as an important virulence feature.
Previous reports have indeed implicated LeTx in the dys-
function of mitochondria in murine macrophages and
human peripheral blood monocytes [6,30].
Anti-apoptotic and stress-responses are favored during 
toxigenic challenge, while cell cycle/differentiation 
responses are favored during non-toxigenic challenge
To further examine specific differences in host response to
each strain, an Analysis of Variance (ANOVA) was per-
formed and genes found to be significant in the cell sur-
vival, stress response, and apoptosis were compared
between different strain challenges under identical condi-
tions (Tables 1, 2, 3). The use of ANOVA here allowed us
to evaluate the differential expression of a particular
human gene while varying 3 conditions: time, MOI, and
the presence or absence of pXO1 in the infecting B. anthra-
cis strain. In our analysis, positive numbers indicate that
the expression levels are higher in the non-toxigenic pXO1
(-) spore treatment, while negative numbers reflect a shift
in expression level favoring the more virulent toxigenic
pXO1 (+) spore treatment. A complete list of genes evalu-
ated in the ANOVA can be found in Additional file 3 of
the Additional Materials.
The ANOVA analysis shows a marked upregulation for
several stress and inflammatory response genes relevant to
the TNF-α biological module in the case of toxigenic
Sterne spore challenge relative to the non-toxigenic Δ
Sterne one (Table 1, 3). Contrasted against the apoptosis-
related genes are the cell cycle genes, which seem to be
affected in response to the non-toxigenic challenge (Table
2), indicating an initial shift towards proliferation and dif-
ferentiation. CXCL2, the chemokine precursor to macro-
phage inflammatory protein-2α (MIP-2α) is strongly
increased in Sterne spore-challenged cells, pointing to a
higher innate response to the toxigenic strain. The apop-
tosis inhibitor genes for cFLAR (CASP8/FADD-Like Apop-
tosis Regulator) and GADD45b (Growth Arrest and DNA-
Damage-inducible, beta) also appear to be expressed
higher in the toxigenic spore treatments (Table 1 and Fig.
5). The level of cFLAR protein determined by Western blot
follows the same trend (Fig. 6a). The increased anti-apop-
totic responses to the toxigenic strain challenge correlate
with the induction of higher transcription of Nf-κB1
(Table 1), a gene which may have some anti-apoptotic
effects[31,32]. In addition the Nf-κB inhibitor QNZ
reduces cFLAR expression (Fig. 6b) in agreement with its
higher level in the toxigenic strain infection (Fig. 6a).
TNF-α-dependent apoptosis during toxigenic infection 
may be countered by cFLAR-and NF-kB-dependent anti-
apoptotic responses
The role of TNF-α, the primary mediator of the cellular
inflammatory response, has attracted significant attentionBMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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Real-Time PCR of single gene treatments confirms trends in microarray expression levels Figure 3
Real-Time PCR of single gene treatments confirms trends in microarray expression levels. Y-axis in microarray 
data (left) represents the fold change in gene expression relative to untreated control samples (labeled control) of THP-1 cells. 
The Y-axis in Real-Time PCR data (right) represents the fold gene expression in the THP-1 cells within the sample relative to 
the level of endogenous 18-S gene expression, and was calculated using the 2-ΔΔCT method described by Livak and Schmitt-
gen[69]. Labels within each panel indicate the time post- exposure, the challenge strain and the MOI.
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Heatmaps of GO-type biological response modules show both similarities and differences in monocytic responses to Sterne  and Δ Sterne B. anthracis strains Figure 4
Heatmaps of GO-type biological response modules show both similarities and differences in monocytic 
responses to Sterne and Δ Sterne B. anthracis strains. MOIs correspond to a 1:1 at the low end of a triangle, and a 1:10 
at the high end of each triangle. Color ranges represent no activation (black), low activation (faint red), and extensive activation 
(full red).
A. Apoptosis and Immune Responses 
B. Cell cycle
C. Stress response BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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in anthrax studies. Recent data indicate that its systemic
levels during infection, or upon LeTx challenge in animals
and cell cultures, are either undetectable or transient
[12,20,33] and therefore cannot be considered as a pri-
mary cause of death, as it was previously suggested
[34,35]. Nevertheless, some data suggest that the TNF-α
response may play an important function in the local host
antibacterial defense [36,37]. In our gene chip and Real-
Time PCR experiments, TNF-α gene expression is signifi-
cantly induced relative to uninfected cells in a time- and
concentration-dependent manner during infection by
both strains (Fig. 5), however the induction by the toxi-
genic strain is approximately 10 times higher, compared
to the non-toxigenic one. This induction correlates with
the increased protein levels of TNF-α determined by ELISA
in the culture medium of cells after spore challenge (Fig.
7). The level of TNF-α is almost 3-fold higher (p < 0.01)
in the cells challenged with the toxigenic spores after 4 h.
This large cellular TNF-α response to toxigenic spores
compared to a lower one in the nontoxigenic spore-chal-
lenge is an interesting observation, suggesting that the
issue of cytokine suppression during anthrax is not
straightforward. It is well known that pXO1 modulates
the expression of many chromosomal proteins in addi-
tion to its own, resulting in larger numbers of unique
secretome proteins in pXO1 (+) strains compared to
pXO1(-) strains[38]. This may contribute to the increased
response to the plasmid (+) strain seen in our study. How-
ever LeTx, a well-known protease of the mitogen-activated
protein kinase kinases (MEKs), would be expected to
inhibit expression of cytokines, and in THP-1 cells, it has
been shown to inhibit the release of TNF-α following
induction by an agonist[39]. In our experiments, the
expression of toxins takes place approximately 2 to 4
hours post-spore challenge, allowing time for a general
innate response before cytokine suppression. Our study
also agrees with a previous report from Pickering et. al.,
who found no inhibition of cytokine response by a toxi-
genic strain, and an even lower response from a non-toxi-
genic strain [12], while other studies, such as those by
Tournier et. al., and Drysdale et. al. have demonstrated the
Table 1: Log ratios of genes of interest in ANOVA analysis* for apoptotic genes
Accession Name Description 2 h 1:1 MOI 2 h 1:10 MOI 4 h 1:1 MOI 4 h 1:10 MOI
NM_001196 BID BH3 interacting domain death agonist -0.0317 -0.0750 -0.6127 -0.5717
NM_015675 GADD45B growth arrest and DNA-damage-inducible, beta -0.0800 -0.5800 -2.0967 -2.0000
XM_046543 MKPX mitogen-activated protein kinase phosphatase x 0.1183 0.5667 0.8563 0.8250
XM_010767 NCKAP1 NCK-associated protein 1 0.1750 0.2333 0.4737 0.2750
NM_006107 OA48-18 acid-inducible phosphoprotein 0.0433 0.0333 0.5737 0.7933
NM_004180 TANK TRAF family member-associated NFKB activator 0.2383 -0.2633 -0.7193 -0.6650
NM_003879 CFLAR CASP8 and FADD-like apoptosis regulator -0.0583 -0.1283 -0.7720 -1.1250
XM_028204 NFKB1 nuclear factor of kappa light polypeptide gene 
enhancer in B-cells 1 (p105)
-0.1467 0.0283 -0.7677 -1.3933
XM_041847 TNF tumor necrosis factor (TNF superfamily, member 2) -0.1683 -0.7250 -2.4107 -1.3967
XM_012894 ZNF14 zinc finger protein 14 (KOX 6) 0.3217 0.2067 0.2593 0.1017
NM_014977 ACINUS apoptotic chromatin condensation inducer in the 
nucleus
0.2867 0.5983 0.0723 -0.5367
*All adjusted P-values < 0.05. Ratios represent comparisons of expression levels of non-toxigenic vs. toxigenic-challenge. (A more comprehensive 
list of genes is shown in the additional materials, Additional file 3).
Table 2: Log ratios of genes of interest in ANOVA analysis* for cell cycle genes
Accession Name Description 2 h 1:1 MOI 2 h 1:10 MOI 4 h 1:1 MOI 4 h 1:10 MOI
XM_034567 CCND2 cyclin D2 0.1833 0.3083 0.5300 0.2267
NM_033379 CDC2 cell division cycle 2, G1 to S and G2 to M 0.0250 0.1783 0.4483 0.5400
NM_002357 MAD MAX dimerization protein 1 0.0150 -0.0433 -0.8050 -0.7250
XM_037657 MYC v-myc myelocytomatosis viral oncogene homolog 
(avian)
0.1233 0.1783 0.6903 0.5983
NM_004725 BUB3 BUB3 budding uninhib. by benzimidazoles 3 homolog 
(yeast)
-0.0500 0.1467 0.4910 0.5767
XM_034725 NRP1 neuropilin 1 -0.0317 0.1583 0.2967 0.5467
XM_008679 TP53 tumor protein p53 0.6183 0.2167 0.6810 -0.1967
NM_005620 S100A11 S100 calcium binding protein A11 (calgizzarin) 0.1667 0.2750 0.4893 0.2567
NM_004705 PRKRIR protein-kinase, interferon-inducible double stranded 
RNA dependent inhibitor, (P58 repressor)
0.0033 -0.0567 0.0303 0.0817
*All adjusted P-values < 0.05 Ratios represent comparisons of expression levels of non-toxigenic vs. toxigenic-challenge.BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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more expected suppression of TNF-α and cytokine
responses upon toxigenic B. anthracis challenge [40,41].
These discrepancies may in part be explained by differ-
ences in the timing mentioned above, but also by the
experimental conditions. Each of these studies attempts to
remove extracellular bacteria and/or excreted proteases/
factors from their models in some way, therefore exclud-
ing their effect. In our conditions, we were interested in
leaving these factors to allow for the evaluation of these
extracellular components in the host cell response of this
LeTx-cytolysis-resistant cell line.
Elevated TNF-α inflammatory response of the THP-1 cells
to the pXO1 gene products is expected to enhance the pro-
tective, bactericidal capacity of macrophages and sensitize
them to apoptosis [42,43]. It is therefore possible that B.
anthracis  has developed a mechanism to counter these
macrophage defenses during the initial infectious activity.
In sensitive macrophages TNF-α is expected to substan-
tially contribute to the apoptotic death program through
a TNF Receptor 1 (TNFR1)-dependent pathway including
activation of caspase-8. An interesting feature of the TNF
signaling network is the existence of extensive cross talk
between the apoptosis and NF-κB signaling pathways that
emanate from TNFR1. While in the absence of NF-κB
activity the cellular susceptibility to TNF-α – induced
apoptosis increases, activation of NF-κB protects against
apoptosis[44,45]. Therefore, the increased TNF-α and NF-
κB expression induced by the toxigenic strain may result
either in the anti-apoptotic effect or in the delay of apop-
tosis onset depending on the balance between the above
stimuli in the TNF-related apoptotic pathway. In agree-
ment with this hypothesis, our data show that apoptosis
detected by TUNEL assay is delayed after 2 h post expo-
sure to the toxigenic strain while after 6 h it takes place to
a similar extent in the case of both strains (Fig. 8).
Discussion
Our results indicate that the THP-1 monocytes present sig-
nificant innate immune responses evident in activation of
several biological modules during both toxigenic, and
non-toxigenic challenge. In general, the early response is
suppressed by the toxigenic strain but overall this strain
demonstrates stronger activation for several stress, inflam-
matory and apoptosis-related genes relevant to the TNF-α
biological module. Observed genotypic responses specific
for the pXO1-encoded pathogenic factors are consistent
with mitochondrial damage, prostaglandin level disrup-
tion, and phosphatase induction likely inhibiting phos-
phoprotein cell signaling. These results agree with the
transcriptional analysis of the murine macrophage RAW
264.7 cells in response to B. anthracis Sterne spore chal-
lenge [46]. The authors reported transcriptional activation
of immune modules, induction of Nf-κB, along with the
apoptotic inhibitor GADD45b. However in the case of un-
stimulated macrophages treated with LeTx there were no
significant changes observed. Analyzing the effect of LeTx
on Salmonella lipopolysaccharide-stimulated RAW 264.7
cells, Tucker et al. detected suppression of the host
immune response [47] however the antigen (LPS) used
for stimulation is irrelevant to anthrax infection. Accord-
ing to our results, the plasmid-negative strain provides the
background information, which is important for precise
evaluation of the pXO1 contribution to the host cell
response, such as silencing of protective signaling in
response to infection and/or changes in signaling mecha-
nisms.
We present evidence that both toxigenic and non-toxi-
genic B. anthracis strains induce apoptosis, which can be
considered as a form of innate immunity against some
pathogens. Our data indicate that in the absence of toxi-
genic pXO1, the infection with the avirulent strain pro-
Table 3: Log ratios of genes of interest in ANOVA analysis* for stress-response genes
Accession Name Description 2 h 1:1 MOI 2 h 1:10 MOI 4 h 1:1 MOI 4 h 1:10 MOI
NM_004040 ARHB ras homolog gene family, B -0.1783 0.0233 -1.7523 -1.5083
NM_002089 CXCL2 chemokine (C-X-C motif) ligand 2 -0.2850 -0.9700 -2.3083 -1.7517
NM_001416 EIF4A1 eukaryotic translation initiation factor 4A, isoform 1 0.1067 0.3233 0.5113 0.5733
NM_005239 ETS2 v-ets erythroblastosis virus E26 oncogene homolog 2 
(avian)
-0.0417 -0.1317 -0.7237 -0.6167
NM_006597 HSPA8 heat shock 70 kDa protein 8 -0.3167 -0.3550 -0.5897 -0.2633
XM_058230 JUND jun D proto-oncogene -0.0883 -0.0133 -0.9497 -0.7983
NM_005566 LDHA lactate dehydrogenase A -0.0150 0.6150 0.8707 1.1967
XM_031818 LYN v-yes-1 Yamaguchi sarcoma viral related oncogene 
homolog
0.0417 -0.2733 -0.6830 -1.0617
XM_008855 NR2F6 nuclear receptor subfamily 2, group F, member 6 0.0183 0.1483 0.3897 0.4650
XM_007258 TNFAIP2 tumor necrosis factor, alpha-induced protein 2 -0.0383 -0.2517 -1.0440 -1.5067
XM_002762 TNFAIP6 tumor necrosis factor, alpha-induced protein 6 -0.0350 -0.1517 -1.5390 -1.0600
NM_003295 TPT1 tumor protein, translationally-controlled 1 -0.4950 -0.5100 -0.3893 -0.4267
* All adjusted P-values < 0.05. Ratios represent comparisons of expression levels of non-toxigenic vs. toxigenic-challenge.BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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ceeds without a substantial intrinsic insult to the cell.
Therefore in the absence of cFLAR induction, and in con-
junction with the observed TNF-α production, we hypoth-
esize that infection in the absence of pXO1 probably
induces apoptosis through a classical extrinsic TNF-α
receptor-mediated caspase-8 pathway. In contrast, the
pXO1-encoded complex of secreted toxins acquired by B.
anthracis as an instrument of intracellular immune eva-
sion causes a strong intracellular insult. The large induc-
tion of CFLAR likely plays some role in inhibiting TNFR-
mediated apoptosis, and may be involved in its observed
phenotypical delay, ultimately pushing the system toward
the intrinsic, mitochondria-dependent pathway of apop-
tosis some time later [48]. This pathway proceeds through
mitochondrial dysfunction, and is a primary differential
observation of our gene ontology modules between the
strains. (Fig. 4), as indicated by the perturbation of mod-
ules containing mitochondrial components in the Sterne-
infected cells. Future experimentation such as the TNFR1-
dependent processing of caspase-8 vs. caspase-9, mito-
chondrial membrane polarization/permeability, and the
formation of apoptotic signaling complexes during chal-
lenge by each of these strains will help to determine if this
is indeed the case.
Fold change of TNF-α and cFLAR expression in THP-1 cells as measured by Real-Time PCR Figure 5
Fold change of TNF-α and cFLAR expression in THP-1 cells as measured by Real-Time PCR. Left panels, B. 
anthracis Sterne infection. Right panels, B. anthracis Δ Sterne infection. Notice the difference in the Y scale between TNF-α pan-
els.
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Interestingly, the onset of apoptosis induced by a toxi-
genic strain is markedly delayed, and bacterial growth is
significantly increased, indicating existence of a mecha-
nism modulating apoptosis in favor of the microbe
through the increased production of anti-apoptotic cFLAR
and Nf-κB. This delay of apoptosis during anthrax infec-
tion could allow for more successful bacterial survival and
dissemination, resulting in systemic disease. This supports
a hypothesis that in anthrax the suppression of apoptosis
in macrophage-like cells may contribute to disease viru-
lence during the initial stages of infection, and that apop-
tosis itself may represent a protective host cell response
until it reaches a pathologic proportion.
Several lines of evidence in the literature support this
hypothesis. Previous analyses of anthrax-infected RAW
264.7 cells [46] identified overexpression of ornithine
decarboxylase (ODC), a normal biosynthetic enzyme
involved in the conversion of putrescine to the
polyamines spermine and spermidine. Since the overpro-
duction of polyamines by ODC has been implicated in
preventing apoptosis [49], this led the authors to specu-
late that ODC overexpression was involved in suppression
of macrophage apoptosis. In the case of other bacterial
infections, apoptosis has been generally considered as a
protective host response [50]. There is additional evidence
that the delay of apoptosis may play roles in some viral
and fungal infections as well [51-53].
Macrophages infected with viable virulent strains of Myco-
bacterium tuberculosis undergo apoptosis with far less fre-
quency than macrophages infected with attenuated strains
[21,22]. Strain virulence in mice correlates directly to the
extent to which apoptosis is inhibited [23]. Thus virulent
strains of M. tuberculosis apparently suppress apoptosis in
host cells. Conversely, macrophage apoptosis appears to
provide the host with a means for killing intracellular
microorganisms, with host cells likely initiating apoptosis
following initial infection [54,55]. Consistent with this,
Mycobacterium Avium, a less virulent pathogen that is less
adapted to the intra-macrophage growth species com-
pared to M. tuberculosis does not suppress macrophage
apoptosis [56].
Mycobacterium infections have been indicated to subvert
pro-apoptotic TNF-α signaling by either reduction of TNF-
α expression or downregulation of its receptor [57], as
well as differential NF-κB activation [58]. It was found
that both virulent and avirulent M. tuberculosis strains acti-
vated NF-κB after 4 h in THP-1 cells however after 48 h
only the virulent strain maintained NF-κB activation,
which lead to up-regulation of a bcl-2 family anti-apop-
totic member, bfl-1/A1. These results indicate that NF-κB
activation may be a determinant factor for the success of
virulent mycobacteria within macrophages. L. pneu-
mophila induces a robust activation of caspase-3 in alveo-
lar macrophages however the apoptotic cell death is not
executed until late stages of the infection, concomitant
with the termination of intracellular replication [59].
Recent studies of hepatitis C infection directly implicate
the sustained upregulation of the cFLAR gene product in
preventing TNF-α-mediated apoptosis and contributing
to disease initiation by the virus core protein [52]. The
induction of cFLAR during toxigenic anthrax infection
likely contributes to prevent apoptosis in a similar fash-
ion, particularly when combined with the suppression of
TNF-α production, as it has been shown that LeTx inhib-
ited the TNF-α production in both endotoxin-stimulated
macrophages [60,61] and anthrax bacterial cell wall-stim-
ulated peripheral blood mononuclear cells [6]. A mecha-
nism consistent with our observations has been suggested
for THP-1 cells stimulated through TLR-4 with the pore-
forming hemolysin, anthrolysin O (AnlO) [54]. In this
report the NF-κB-dependent activation of Bfl-1/A1 gene by
AnlO contributed to anti-apoptotic signaling, although
overall the TLR-4 stimulation resulted in apoptosis. How-
ever the role of AnlO in vivo remains to be elucidated.
Another possible pathway of apoptosis inhibition in mac-
CFLAR protein induction in THP-1 cells Figure 6
CFLAR protein induction in THP-1 cells. A. Western 
blots of CFLAR induction at MOIs 1:1 and 1:10 at 4 h post 
infection. B. Inhibition of NF-κB with the inhibitor QNZ dur-
ing challenge suppresses the production of cFLAR. Samples 
were taken at 8 h post infection at MOI 1:1. C denotes 
unchallenged control; S, challenge with Sterne strain; and ΔS, 
challenge with Δ Sterne strain. Actin is shown as a control.BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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rophages includes EdTx-mediated activation of the anti-
apoptotic Platelet Activator Inhibitor type 2 gene (PAI-2),
although THP-1 cells carry an inactivating mutation in
this gene [46].
The previous findings that anthrax LeTx inhibits the p38
signaling pathway by cleavage of MAPKKs in macro-
phages and dendritic cells [60,62] are consistent with the
protective role of this stress-activated pathway in elimina-
tion of intracellular pathogens and activation of host
immunity [63]. From this standpoint, the proteolytic
activity of LeTx on the MAPK activation pathway may con-
tribute to establishing infection by preventing cell activa-
tion in response to infection and thereby increasing the
bacterial survival within phagocytes [19,60].
Conclusion
Using a matched pair of the pXO1 (+) and pXO1 (-) B.
anthracis strains, we demonstrate that the monocyte-type
THP cells in vitro generate a distinct set of transcriptional
responses to infection characteristic of the virulence fac-
tors contributed by the XO1 plasmid. Among these
responses, the delay of apoptosis associated with the ele-
vated expression of anti-apoptotic cFLAR represents a
likely pathogenic strategy directed toward bacterial sur-
vival in the conditions of the increased host inflammatory
response. This may be particularly relevant for hosts carry-
ing mononuclear cells which, like THP-1, are resistant to
LeTx-induced cytolysis. In the absence of pXO1, the non-
toxigenic strain induces early apoptosis consistent with its
protective role in several infectious diseases as a form of
the host innate immune response. This finding implies
that in addition to LeTx, virulent B. anthracis possesses a
chromosome-encoded factor(s) triggering a pro-apoptotic
host response, as well as the plasmid factors counterbal-
ancing apoptosis.
Production of TNF-α protein mirrors transcriptional results Figure 7
Production of TNF-α protein mirrors transcriptional results. ELISA of TNF-α produced by THP-1 cells challenged by 
Sterne and Δ Sterne over 8 h.
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Methods
Bacterial strains and THP-1 cell cultures
Bacillus anthracis strain 34F2 Sterne (pXO1+, pXO2-) was
obtained from Colorado Serum Company (CO). Δ Sterne
strain, from the Collection of the National Center for Bio-
defense and Infectious Diseases (George Mason Univer-
sity, Manassas, VA), is a plasmidless derivative of Sterne
strain generated by curing of the pXO1 plasmid by growth
for 6 days in LB media at 42.5°C [64]. In our experiments,
the absence of pXO1 in the cured strain was confirmed by
PCR with the protective antigen-specific primers. B.
anthracis is one of the most monophyletic bacterial strains
known, however the introduction of genomic changes by
the curing process cannot be discounted. Despite the uni-
formity of its genome, B. anthracis strains do contain
sequences which exhibit variability in response to selec-
tive pressures and allow differentiation. As it is not possi-
ble to test all genomic sequence without considerable
time and expense, we therefore applied a high-resolution
multi locus sequence typing using the technique and
primers of Helgeson [65] to ensure that both strains were
at least identical for all variable sequences tested (Addi-
tional file 2) Growth curves for both strains were also
identical in 1% fetal bovine serum (FBS) cell culture
medium, with 4 h corresponding to the mid point of the
exponential phase of growth (Additional file). Spores
were generated by growth for 4 days on LB agar plates fol-
lowed by re-suspension in water and pelleting by centrif-
ugation two to four times, then storage in water at 4°C
until use.
THP-1 was obtained from ATCC (Manassas, VA) and
grown in complete medium (RPMI 1640 with glutamine,
25 mM HEPES, 4.5 g/l glucose, and 10% FBS) for propa-
gation, until 24 h before challenge with spores, at which
point THP-1 cells were washed and re-suspended for 24 h
in serum-free (low protein) Cellgro media (Media Tech,
Herndon, Va.) at a concentration of 1.0 × 106 cells/ml.
Cell cultures were challenged for 2 h or 4 h at a cell to
spore multiplicity of infection (MOI) of either 1:1 or 1:10
for microarray experiments. The term MOI used here sim-
ply refers to the number of spores added per cell. Each
timepoint/MOI combination was replicated at least 3
times for OD readings and microarray analysis. Viability
was measured by a standard Trypan Blue permeability
assay by counting dead cells with a hemocytometer. Infec-
Apoptosis of THP-1 cells is delayed at 2 h post challenge by the toxigenic Sterne strain relative to the non-toxigenic Δ Sterne  strain Figure 8
Apoptosis of THP-1 cells is delayed at 2 h post challenge by the toxigenic Sterne strain relative to the non-tox-
igenic Δ Sterne strain. Apoptosis was detected with TUNEL staining. The numbers on the images show counts of objects 
with the intensities above background relative to corresponding untreated controls and indicate the extent of apoptosis. DAPI 
staining shows that equal number of cells was used in all experiments.BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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tion of THP-1 monocytes by both strains for 4 h in the
conditions of our experiments resulted in a viability of
greater than 90% relative to untreated cells.
Microarrays and ANOVA analysis
RNA was collected and purfied immediately at the appo-
priate timepoints by Trizol (Invitrogen Corporation,
Carlsbad, CA), and quality determined by checking on a
Lab-on-a-Chip Bioanalyzer 2100 (Agilent Technologies,
Santa Clara, CA). Samples were similarly quality checked
after both probe labelling and hybridizations steps. The
microarray platform was developed, printed, hybridized
and analyzed at Avalon Pharmaceuticals, Inc.(German-
town, MD). Probe design and printing were all done using
automated, proprietary processes (Avalon Pharmacueti-
cals, Germaintown, Md) and contained quality control
steps after each. Arrays consist of proprietary 80-mer long,
spotted oligonucleotides representing 2,000 human
genes. Each chip contains four replicates of each gene
(8,000 total/chip) with 64 perfect match and 64 mis-
match controls. Arrays were hybridized using standard
Cy3/Cy5 sample/reference labeling and analyzed using a
ScanArray reader (Perkin-Elmer, Wellesly, MA). Several
sets of genes related to apoptosis, stress response, and cell
differentiation were chosen for further evaluation. To
determine whether these genes were differentially
expressed between two experimental states, an ANOVA
was performed on the log-transformed expression ratios
as described in [66]. The following model was used for
this analysis: yijkl = Ei + Mj + Tk + (EMT)ijkl + εijkl where yijkl
denotes the log2 expression ratio measured for experimen-
tal state i, MOI j, time state k, replicate l, with 1 ≤ i ≤ 3, 1
≤ j ≤ 2, 1 ≤ k ≤ 2, and 1 ≤ l ≤ 6. The term Ei measures the
effect of the infection; Mj measures the effect of the MOI;
Tk measures the effect of the time state, and the term
(EMT)ijkl measures the interaction effect of all three varia-
bles. An ANOVA was performed on each gene using the
linear model above. Twelve contrasts were based on pair-
wise differences between each experimental condition
and the control state, as well as the experimental state
which differed in the MOIs only. The R package limma
was used for ANOVA methods [67]. A multiple testing
correction [68] controlled the false discovery rate, which
is the expected proportion of false positives in the rejected
hypotheses. Genes with adjusted F-statistic p-values < 0.05
were collected for further inspection.
Real-Time PCR
To confirm microarray data, Real-Time PCR was per-
formed using the iQ SYBR Green kit from BIO-RAD (Her-
cules, CA) using the manufacturers specifications. Real
time data for each gene represents the average of 3 biolog-
ical replicates, each replicated 3 times for a total of 9 reac-
tions per gene/treatment. Fold expression was calculated
for each gene relative to an endogenous 18-S control gene
using the 2-ΔΔCT method as described[69]. Primers chosen
for Real-Time analysis were as follows: The human 18-S
ribosomal gene (18S), 5'AGGAATTCCCAGTAAGTGCG
and 5'GCCTCACTAAACCATCCAA; Tumor necrosis fac-
tor-α (TNF superfamily, member 2; TNF-α), 5'TGTCT-
CAACCCCGCATCG and 5'AGGAACAGCCACCAATAAG
C; Ras-related C3 botulinum toxin substrate 2 (Rho fam-
ily, small GTP-binding protein Rac2; RAC2), 5'CCTCAT-
CATCCAGTCCAACG and 5'GGCGAACTCCTGCTCCTC;
Chemokine (C-X-C motif) ligand 2 (CXCL2), 5' TGTCT-
CAACCCCGCATCG and 5' AGGAACAGCCACCAATAAG
C; CASP8/FADD-like apoptosis regulator (cFLAR), 5'AGA
TCACCAGCCTTACCG and 5'GATGAGCCACAGGAAAT
GC. Tms used in Real-Time cyclers were 54.3°C for TNF-α,
cFLAR, and 18-S genes; 52.9°C for the RAC gene; and
63.2°C for the CXCL2 gene.
Representation of biological response modules
Expression values of genes from each of three replicate
chips for each treatment were averaged, and genes corre-
sponding to specific gene ontology (GO) categorizations
(modules) http://www.godatabase.org. were clustered
using 'Cluster' http://rana.lbl.gov/EisenSoft
ware.htm[34,70]. Clustering was performed without
additional filtering or adjustment, using the uncentered
correlation coefficient, followed by complete linkage clus-
tering.
Western Blot Analysis and ELISA
For Western blot analysis, spore-treated THP-1 cells were
lysed in a buffer containing 25 mM Tris-HCl, pH 7.6, 150
mM NaCl, 1% NP-40, 1% sodium deoxycholate and 0.1%
SDS (RIPA buffer, Pierce) and cell debris was removed by
centrifugation. Resulting proteins were separated in a 4–
20% gradient gel and electrophoretically transferred to a
PVDF membrane. The membrane was probed with mouse
monoclonal antibodies against cFLAR (Abnova), and
actin (Chemicon), and then the horseradish peroxidisase-
conjugated anti-mouse secondary antibody. To quantify
TNF-α proteins secreted into culture medium, human
TNF-α ELISA was performed according to the manufac-
turer's recommendation (BD Biosciences). The culture
supernatants were collected by centrifugation of THP-1
cells cultured in a serum-free medium at the indicated
time point post spore challenge. To investigate whether
NF-kB is involved in cFLAR expression, 10 μM NF-kB
inhibitor 6-amino-4-(4-phenoxyphenylethylamino)
quinazoline, a cell-permeable quinazoline (QNZ, Sigma),
was added to THP-1 cell culture 30 min prior to treatment
with spores (MOI 1). After incubation for 8 h, cells were
lysed in RIPA buffer and analyzed by Western blotting as
described above.
Apoptosis Detection
For detection of apoptosis, terminal dUTP nick-end labe-
ling (TUNEL) assay was performed according to manufac-
turer's recommendation (Roche Applied Science). Briefly,BMC Immunology 2008, 9:67 http://www.biomedcentral.com/1471-2172/9/67
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the spore-challenged THP-1 cells were washed 3 times
with phosphate-buffered saline (PBS), and fixed with 2%
paraformaldehyde for 60 min at room temperature. The
cells were washed with PBS and permeabilized with 0.1%
Triton X-100 in 0.1% sodium citrate for 2 min. TUNEL
reaction was carried out for 60 min at 37°C in a humidi-
fied atmosphere by adding 50 μL of reaction mixture con-
taining terminal deoxynucleotidyl transferase. The
TUNEL-positive cells were analyzed under a fluorescence
microscope. The number of objects with the intensities
above background on the images was determined using
the Elements software (NikonNicon).
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